Cargando…
Correction: Kao et al. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655
Autores principales: | Kao, Chieh-Ni, Moi, Sin-Hua, Hou, Ming-Feng, Luo, Chi-Wen, Chen, Fang-Ming, Pan, Mei-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953598/ https://www.ncbi.nlm.nih.gov/pubmed/35330508 http://dx.doi.org/10.3390/jpm12030466 |
Ejemplares similares
-
RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
por: Kao, Chieh-Ni, et al.
Publicado: (2021) -
KAOS: a new automated computational method for the identification of overexpressed genes
por: Nuzzo, Angelo, et al.
Publicado: (2016) -
Combining Two Modelling Approaches: GQM and KAOS in an Open Source Project
por: Askarbekuly, Nursultan, et al.
Publicado: (2020) -
Professor Chi-Chang Kao Director SLAC National Accelerator Laboratory United States of America
por: Bennett, Sophia Elizabeth
Publicado: (2016) -
Draft Genome Sequence of Halomonas sp. Strain KAO, a Halophilic Mn(II)-Oxidizing Bacterium
por: Lee, Cameron J., et al.
Publicado: (2021)